Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AMR”

85 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 85 results

Testing effectiveness (Phase 2)Ended earlyNCT01331824
What this trial is testing

Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial Carcinoma

Who this might be right for
Bladder Cancer
Matthew Galsky 22
Not applicableStudy completedNCT03737136
What this trial is testing

Comparison Between Bortezomib and Rituximab Plus Plasmapheresis in AMR

Who this might be right for
Antibody-mediated Rejection
Shahid Beheshti University of Medical Sciences 20
Early research (Phase 1)Looking for participantsNCT06990711
What this trial is testing

Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation

Who this might be right for
Antibody Mediated Rejection of Lung Transplant
Washington University School of Medicine 30
Large-scale testing (Phase 3)Ended earlyNCT03994783
What this trial is testing

Transplant Antibody-Mediated Rejection: Guiding Effective Treatments

Who this might be right for
Kidney Transplant RejectionAntibody-mediated Rejection
Imperial College London 3
Not applicableUnknownNCT03622177
What this trial is testing

Role of the IL33/Amphiregulin Pathway as a Potential Therapeutic Target in HIV Infection

Who this might be right for
HIV I Infection
ANRS, Emerging Infectious Diseases 180
Testing effectiveness (Phase 2)Study completedNCT01259375
What this trial is testing

Amrubicin Chemotherapy as First Line in Metastatic or Unresectable Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
University of Utah 24
Testing effectiveness (Phase 2)Study completedNCT00388960
What this trial is testing

Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Celgene 99
Not applicableLooking for participantsNCT06651047
What this trial is testing

PK/PD Analysis of Ceftazidime/Avibactam or Cefiderocol With or Without Fosfomycin for the Treatment of Difficult To-treat Gram-negative Infections

Who this might be right for
Gram Negative InfectionAntimicrobial Resistance (AMR)
University of Bologna 120
Not applicableLooking for participantsNCT06821282
What this trial is testing

Surveillance of AMR in DRC

Who this might be right for
Bacteremia
University of Oxford 210
Large-scale testing (Phase 3)Study completedNCT00547651
What this trial is testing

AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy

Who this might be right for
Small Cell Lung Cancer
Celgene 637
Large-scale testing (Phase 3)Study completedNCT03545373
What this trial is testing

Accuracy and Consequences of Using Trial-of-antibiotics for TB Diagnosis (ACT-TB Study)

Who this might be right for
TuberculosisRespiratory Tract InfectionsPneumonia
London School of Hygiene and Tropical Medicine 1,583
Not applicableStudy completedNCT06508398
What this trial is testing

Healthcare-Associated Infections in Ukraine and the Activity of 4-Thiazolidinone Derivatives Against Related Pathogens

Who this might be right for
Nosocomial Infection
Danylo Halytsky Lviv National Medical University 250
Testing effectiveness (Phase 2)Ended earlyNCT01904253
What this trial is testing

Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy

Who this might be right for
Small Cell Lung Cancer (SCLC)
Taiho Oncology, Inc. 18
Not applicableLooking for participantsNCT06430775
What this trial is testing

Exploring Prolonged AMR in ACL Reconstructed Patients

Who this might be right for
Anterior Cruciate Ligament InjuriesAnterior Cruciate Ligament RuptureAnterior Cruciate Ligament Tear+6 more
University Ghent 190
Very early researchEnded earlyNCT03380936
What this trial is testing

Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
University of Colorado, Denver 4
Not applicableLooking for participantsNCT05017766
What this trial is testing

NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria

Who this might be right for
Antimicrobial Resistance (AMR)
University Hospital, Basel, Switzerland 8,000
Post-approval studies (Phase 4)Looking for participantsNCT05979545
What this trial is testing

EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics

Who this might be right for
Blood Stream InfectionsVentilator Associated PneumoniaHealthcare Associated Infection+2 more
National University of Singapore 1,900
Not applicableUnknownNCT03818477
What this trial is testing

Environmental Surveillance (ES) for Polio and AMR Using the TaqMan Array Card

Who this might be right for
Polio
University of Virginia 8,500
Not applicableLooking for participantsNCT07261969
What this trial is testing

CRP and Patient Information Leaflets to Optimise Antibiotic Treatments for Adults With Respiratory Tract Infections in Primary Care in Kyrgyzstan

Who this might be right for
Respiratory Tract Infection BacterialRespiratory Tract Infection ViralAMR+2 more
Rigshospitalet, Denmark 1,050
Testing effectiveness (Phase 2)Ended earlyNCT01399593
What this trial is testing

Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization

Who this might be right for
Antibody Mediated Rejection
Alexion Pharmaceuticals, Inc. 102
Load More Results